These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6116521)

  • 21. Individual motor activity--relationships to dopaminergic responses.
    Schumacher HE; Oehler J; Jaehkel M
    Pharmacol Biochem Behav; 1994 Aug; 48(4):839-44. PubMed ID: 7972286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice.
    Skrinskaya JA; Nikulina EM; Popova NK
    Pharmacol Biochem Behav; 1992 Jun; 42(2):261-7. PubMed ID: 1385878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic variation in striatal calmodulin content.
    Severson JA
    Brain Res; 1985 Aug; 340(1):79-86. PubMed ID: 2992708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
    Conti LH; Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
    Feldman DJ; Frank RA; Kehne JH; Flannery R; Brown D; Soni S; Byrd G; Shah S
    Pharmacol Biochem Behav; 1997 Oct; 58(2):565-72. PubMed ID: 9300620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system.
    Nakamura T; Uramura K; Nambu T; Yada T; Goto K; Yanagisawa M; Sakurai T
    Brain Res; 2000 Aug; 873(1):181-7. PubMed ID: 10915829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locomotor response to novelty correlates with the number of midbrain tyrosine hydroxylase positive cells in rats.
    Jerzemowska G; Plucińska K; Kulikowski M; Trojniar W; Wrona D
    Brain Res Bull; 2012 Jan; 87(1):94-102. PubMed ID: 22056623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
    Flório JC; Palermo-Neto J
    Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine.
    Fink JS; Smith GP
    Brain Res; 1980 Nov; 201(1):107-27. PubMed ID: 7191345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
    de Bruin NM; van Luijtelaar EL; Cools AR; Ellenbroek BA
    Behav Pharmacol; 2001 Nov; 12(6-7):517-25. PubMed ID: 11742146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain differences in pituitary prolactin content: relationship to number of hypothalamic dopamine neurons.
    Baker H; Sved AF; Tucker LW; Alden SM; Reis DJ
    Brain Res; 1985 Dec; 358(1-2):16-26. PubMed ID: 2866817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered baseline and amphetamine-mediated behavioral profiles in dopamine transporter Cre (DAT-Ires-Cre) mice compared to tyrosine hydroxylase Cre (TH-Cre) mice.
    Chohan MO; Esses S; Haft J; Ahmari SE; Veenstra-VanderWeele J
    Psychopharmacology (Berl); 2020 Dec; 237(12):3553-3568. PubMed ID: 32778904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
    Grabowska M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1991 May; 39(1):61-70. PubMed ID: 1924514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.